Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Milmedtek International AB
AB
Dissolved
Org 5568587249
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2011
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2017
SEK 204K
-93% vs 2016
EBITDA margin
-14.2%
-105% vs 2016
Equity ratio
17.2%
Financial strength
Net profit 2017
SEK 2K
-99% vs 2016
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2016
0M
-100%
2017
Key figures
Annual report 2017
Revenue
SEK 204K
-93%
EBITDA
SEK -29K
-105%
Net profit
SEK 2K
-99%
Total assets
SEK 2,7M
-25%
Equity
SEK 465K
+0%
Employees
0
—
Company information
Legal name
Milmedtek International AB
Org number
5568587249
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
5 juli 2011
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2017-06-30
Financial year
January – December
Company purpose
Aktiebolagets verksamhet ska vara att bedriva internationell försäljning och service av medicinteknisk utrustning jämte därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
3M
2016
0M
2017
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2016
0M
2017
Income statement
SEK thousands
Item
2016
2017
Revenue
2 899
204
Staff expenses
—
—
EBITDA
625
−29
Depreciation & amort.
−0
−0
EBIT
625
−29
Net financials
−22
−43
Profit before tax
453
3
Tax
−100
−1
Net profit
353
2
Balance sheet
SEK thousands
Item
2016
2017
Total assets
3 602
2 704
Equity
464
465
Long-term debt
1 525
1 425
Short-term debt
838
114
Total debt
2 363
1 539
Financial ratios
5-year trend
EBITDA margin
-14.2%
This company
15.8%
Market median
-190% vs market
2016
2017
Equity ratio
17.2%
This company
38.2%
Market median
-55% vs market
2016
2017
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
2016
2017
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
2016
2017
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
2016
2017
Debt / equity
4.82×
This company
0.62×
Market median
-677% vs market
2016
2017
Annual reports & filings
Annual report 2017
Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
TB
Tibor Bondesson
Audit
Audit
2019
BP
Bror Per Mikael Larsson
Chief Executive Officer
Chief Executive Officer
2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
UA
Ulla Anette Elisabet Larsson
Deputy Board Member
2019
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Milmedtek International AB also hold positions in
0
other companies.
Person
Role here
Other companies
Tibor Bondesson
Audit
0 companies
Bror Per Mikael Larsson
Chief Executive Officer
0 companies
Ulla Anette Elisabet Larsson
Deputy Board Member
0 companies